Chemotherapy and the somatic mutation burden of sperm
Authors:
- Shany PicciottoSPShany Picciotto
- Camilo Arenas-GalloCACamilo Arenas-Gallo
- Amos TorenATAmos Toren
- Ruty Mehrian-ShaiRMRuty Mehrian-Shai
- Bryan DalyBDBryan Daly
- Stephen RhodesSRStephen Rhodes
- Megan PruntyMPMegan Prunty
- Ruolin LiuRLRuolin Liu
- Anyull BohorquezABAnyull Bohorquez
- Marta Grońska-PęSkiMGMarta Grońska-PęSki
- Shana MelanaphySMShana Melanaphy
- Pamela CallumPCPamela Callum
Open Access
- 6 May 2025
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (12)
Abstract
Many chemotherapeutic agents impair cancer growth by inducing DNA damage. The impact of these agents on mutagenesis in normal cells, including sperm, is largely unknown. Here, we applied high-fidelity duplex sequencing to 94 samples from 36 individuals exposed to diverse chemotherapies and 32 controls. We found that in many of the sperm samples from men exposed to chemotherapy, the mutation burden was elevated as compared with controls and the expected burden based on trio studies, with 1 patient having a more than 10-fold increase over that expected for age. Saliva from this same individual also had a markedly higher mutation burden. We then validated this finding using other tissues, also finding an increased mutation burden in the blood and liver of many patients exposed to chemotherapy as compared with unexposed controls. Similarly, mice treated with 3 cycles of cisplatin had an increased mutation burden in sperm but also in the liver and hematopoietic progenitor cells. These results suggest an association between cancer therapies and mutation burden, with implications for counseling patients with cancer considering banking sperm before therapy and for cancer survivors considering the trade-offs of using banked sperm as compared with conceiving naturally.Keywords
Funding Information
- National Institutes of Health (5R21HD105910-02)
This publication has 58 references indexed in Scilit:
- The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational studyThe Lancet Oncology, 2024
- Use of fertility preservation services in male reproductive-aged cancer patientsGynecologic Oncology Reports, 2021
- Paternal Age at Childbearing and Offspring Psychiatric and Academic MorbidityJAMA Psychiatry, 2014
- Effects of chemotherapy and radiotherapy on spermatogenesis in humansFertility and Sterility, 2013
- Deciphering Signatures of Mutational Processes Operative in Human CancerCell Reports, 2013
- Detecting and Estimating Contamination of Human DNA Samples in Sequencing and Array-Based Genotype DataThe American Journal of Human Genetics, 2012
- Sporadic autism exomes reveal a highly interconnected protein network of de novo mutationsNature, 2012
- Clonal evolution in cancerNature, 2012
- Cisplatin‐Induced Long‐term Failure of Spermatogenesis in Adult C57/Bl/6J MiceJournal of Andrology, 2005
- The origins, patterns and implications of human spontaneous mutationNature Reviews Genetics, 2000